neuroendocrine malignancies
Showing 1 - 25 of 3,569
Neuroendocrine Tumors Trial in New York (radiation, device, other)
Recruiting
- Neuroendocrine Tumors
- 18F-MFBG (meta-fluoro benzylguanidine)
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Mar 31, 2022
Neuroendocrine Tumor Trial in Beijing (18F-MFBG)
Recruiting
- Neuroendocrine Tumor
-
Beijing, Dongcheng, ChinaPeking union medical college hospital
Sep 25, 2021
Pancreatic Cancer Dietary Assessment Study
Completed
- Pancreatic Neoplasm
- +3 more
- Pancreo-KIT breath test
-
Manchester, United KingdomThe Christie NHS Foundation Trust
Feb 1, 2022
Solid Organ Malignancies, Adenoidcystic Carcinoma, Neuroendocrine Tumors Trial in Atlanta (Lenalidomide, Everolimus)
Completed
- Solid Organ Malignancies
- +2 more
-
Atlanta, Georgia
- +1 more
Nov 19, 2021
Small Cell Lung Cancer, Gastric Adenocarcinoma, Esophageal Adenocarcinoma Trial in United States (PDR001, LAG525)
Completed
- Small Cell Lung Cancer
- +7 more
- PDR001
- LAG525
-
San Francisco, California
- +19 more
May 4, 2022
Neuroendocrine Neoplasms Including Adrenocortical Carcinoma
Recruiting
- Neuroendocrine Tumors
- Carcinoma, Neuroendocrine
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
Urothelial Cancer and Rare Genitourinary Tract Malignancies
Recruiting
- Urothelial Cancer
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Advanced Biliary Tract Cancer, Neuroendocrine Tumors, Female Reproductive System Tumor Trial in Australia (Ipilimumab,
Recruiting
- Advanced Biliary Tract Cancer
- +3 more
-
Albury, New South Wales, Australia
- +11 more
Oct 31, 2022
Neuroendocrine Carcinomas, Neuroendocrine Tumors, Carcinoma, Neuroendocrine Trial run by the National Cancer Institute (NCI)
Not yet recruiting
- Neuroendocrine Carcinomas
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Sep 22, 2023
Multi-dimensional Fragmentomic Assay for Early Detection of
Not yet recruiting
- Pancreatic Neuroendocrine Tumor
- Fragmentomic profiles of plasma cfDNA
- (no location specified)
Apr 27, 2023
GastroIntestinal Cancer in Children and Adolescents
Active, not recruiting
- Gastrointestinal Cancer
- +6 more
-
Leiden, South-Holland, Netherlands
- +1 more
Jan 11, 2023
Digestive System Neuroendocrine Tumor G1, Digestive System Neuroendocrine Tumor G2, Metastatic Digestive System Neuroendocrine
Not yet recruiting
- Digestive System Neuroendocrine Tumor G1
- +5 more
- Tumor Debulking
- +5 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Aug 23, 2023
Advanced Pancreatic Cancer, Solid Tumor Malignancies Trial run by the (ProAgio)
Recruiting
- Advanced Pancreatic Cancer
- Solid Tumor Malignancies
-
Bethesda, MarylandNational Cancer Institute
Sep 26, 2022
Neuroendocrine Tumor, Paraganglioma, Carcinoid Tumors Trial in San Francisco (Computed Tomography (CT), Gallium Ga
Terminated
- Neuroendocrine Tumor
- +3 more
- Computed Tomography (CT)
- +3 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Oct 21, 2019
Neuroendocrine Tumor of Pancreas, Multiple Endocrine Neoplasia Type 1 Trial in Utrecht (High-dose-high precision MR-guided
Recruiting
- Neuroendocrine Tumor of Pancreas
- Multiple Endocrine Neoplasia Type 1
- High-dose-high precision MR-guided radiotherapy
-
Utrecht, NetherlandsUMC Utrecht
May 29, 2022
Neuroendocrine Tumors, Non-hematologic Malignancy Trial in Japan (Surufatinib)
Recruiting
- Neuroendocrine Tumors
- Non-hematologic Malignancy
-
Fukuoka, Japan
- +11 more
Feb 1, 2022
(PRRT) for the Treatment of Neuroendocrine Tumors
Enrolling by invitation
- Neuroendocrine Tumors
- Peptide Receptor Radionuclide Therapy
-
Dallas, TexasMethodist Dallas Medical Center
Oct 27, 2021
Neuroendocrine Tumor Grade 2, Neuroendocrine Tumors Trial in Little Rock, Buffalo, Philadelphia (Capecitabine Oral Product,
Recruiting
- Neuroendocrine Tumor Grade 2
- Liver Metastases
- Capecitabine tablets + temozolomide tablets + SIR-Spheres
-
Philadelphia, PennsylvaniaAbramson Cancer Center
Oct 1, 2021
Pancreatic Cancer, Thyroid Cancer, Lung Cancer Trial in United States
Recruiting
- Pancreatic Cancer
- +49 more
-
Colorado Springs, Colorado
- +80 more
Feb 22, 2022
Advanced Malignancies Trial in Shanghai (IBI323)
Recruiting
- Advanced Malignancies
-
Shanghai, Shanghai, ChinaShang Hai Pulmonary Hospital
Sep 3, 2021